Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M UNGER

Showing results (471-480 of 604) with videos related to

Pageof 61
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2002
Adjuvant immunotherapy of resected, intermediate-thickness, node-negative melanoma with an allogeneic tumor vaccine: impact of HLA class I antigen expression on outcomeJeffrey A Sosman, Joseph M Unger, P-Y Liu, et al.
Antimicrobial Agents and Chemotherapy|December 30, 2015
Doripenem Treatment during Continuous Renal Replacement TherapyM G Vossen, J M Wenisch, A Maier-Salamon, et al.
Journal of the National Cancer Institute. Monographs|February 24, 2025
Best practices and pragmatic approaches for patient-reported outcomes and quality of life measures in cancer clinical trialsHanna Bandos, Pedro A Torres-Saavedra, Eva Culakova, et al.
Cancer|January 9, 2020
Association between nonadherence to cardiovascular risk factor medications after breast cancer diagnosis and incidence of cardiac eventsDawn L Hershman, Melissa K Accordino, Sherry Shen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2001
Infusional CHOP chemotherapy (CVAD) with or without chemosensitizers offers no advantage over standard CHOP therapy in the treatment of lymphoma: a Southwest Oncology Group StudyE R Gaynor, J M Unger, T P Miller, et al.
Leukemia|July 11, 2008
Absolute quantitative detection of ABL tyrosine kinase domain point mutations in chronic myeloid leukemia using a novel nanofluidic platform and mutation-specific PCRV G Oehler, J Qin, R Ramakrishnan, et al.
Cancer|December 19, 2018
Acquisition of sexual orientation and gender identity data among NCI Community Oncology Research Program practice groupsElizabeth J Cathcart-Rake, Tyler Zemla, Aminah Jatoi, et al.
Blood|February 8, 2008
Total body irradiation, etoposide, cyclophosphamide, and autologous peripheral blood stem-cell transplantation followed by randomization to therapy with interleukin-2 versus observation for patients with non-Hodgkin lymphoma: results of a phase 3 randomized trial by the Southwest Oncology Group (SWOG 9438)John A Thompson, Richard I Fisher, Michael Leblanc, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 10, 2010
Real-time visualization of altered gastric motility by magnetic resonance imaging in patients with Parkinson's diseaseMarcus M Unger, Katja Hattemer, Jens C Möller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2001
Phase III randomized intergroup trial of subtotal lymphoid irradiation versus doxorubicin, vinblastine, and subtotal lymphoid irradiation for stage IA to IIA Hodgkin's diseaseO W Press, M LeBlanc, A S Lichter, et al.
Pageof 61

Showing results (471-480 of 604) with videos related to

Sort By:
Pageof 61
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2002
Adjuvant immunotherapy of resected, intermediate-thickness, node-negative melanoma with an allogeneic tumor vaccine: impact of HLA class I antigen expression on outcomeJeffrey A Sosman, Joseph M Unger, P-Y Liu, et al.
Antimicrobial Agents and Chemotherapy|December 30, 2015
Doripenem Treatment during Continuous Renal Replacement TherapyM G Vossen, J M Wenisch, A Maier-Salamon, et al.
Journal of the National Cancer Institute. Monographs|February 24, 2025
Best practices and pragmatic approaches for patient-reported outcomes and quality of life measures in cancer clinical trialsHanna Bandos, Pedro A Torres-Saavedra, Eva Culakova, et al.
Cancer|January 9, 2020
Association between nonadherence to cardiovascular risk factor medications after breast cancer diagnosis and incidence of cardiac eventsDawn L Hershman, Melissa K Accordino, Sherry Shen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2001
Infusional CHOP chemotherapy (CVAD) with or without chemosensitizers offers no advantage over standard CHOP therapy in the treatment of lymphoma: a Southwest Oncology Group StudyE R Gaynor, J M Unger, T P Miller, et al.
Leukemia|July 11, 2008
Absolute quantitative detection of ABL tyrosine kinase domain point mutations in chronic myeloid leukemia using a novel nanofluidic platform and mutation-specific PCRV G Oehler, J Qin, R Ramakrishnan, et al.
Cancer|December 19, 2018
Acquisition of sexual orientation and gender identity data among NCI Community Oncology Research Program practice groupsElizabeth J Cathcart-Rake, Tyler Zemla, Aminah Jatoi, et al.
Blood|February 8, 2008
Total body irradiation, etoposide, cyclophosphamide, and autologous peripheral blood stem-cell transplantation followed by randomization to therapy with interleukin-2 versus observation for patients with non-Hodgkin lymphoma: results of a phase 3 randomized trial by the Southwest Oncology Group (SWOG 9438)John A Thompson, Richard I Fisher, Michael Leblanc, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 10, 2010
Real-time visualization of altered gastric motility by magnetic resonance imaging in patients with Parkinson's diseaseMarcus M Unger, Katja Hattemer, Jens C Möller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2001
Phase III randomized intergroup trial of subtotal lymphoid irradiation versus doxorubicin, vinblastine, and subtotal lymphoid irradiation for stage IA to IIA Hodgkin's diseaseO W Press, M LeBlanc, A S Lichter, et al.
Pageof 61